Implantable Defibrillators in Children: From Whence to Shock

Friedman, Richard A.; Garson, Margaret

doi:10.1046/j.1540-8167.2001.00361.x

Cited by 12 publications

(5 citation statements)

References 1 publication

Supporting

Mentioning

Contrasting

Order By: Relevance

“…[24][25][26][27][28] Each of these patient-specific adaptations, however, still required some form of transvenous or epicardial sensing electrodes. Also, these were primarily adapted to developments in patient clinical status, surgical limitations or lead failures, and the clinically limited options to repair the previously implanted intrathoracic defibrillation lead system.…”

Section: Prelude To First Use Of Stand-alone Subcutaneous Defibrillatormentioning

confidence: 99%

“…Children are another group likely to benefit substantially. Present technology in children requiring ICDs is associated with a disturbing frequency of serious complications, which reflects their smaller veins and more rapid growth rates 24,25 (see Chapter 18). Also, we are currently exploring the value of the S-ICD in women because it is unlikely to interfere with mammography; neither the lead nor the generator is within the breast tissue.…”

Section: Overview Of Experience To Datementioning

confidence: 99%

See 1 more Smart Citation

Subcutaneous Implantable Cardioverter-Defibrillators

Smith¹,

Bardy²,

Hood³

et al. 2011

Clinical Cardiac Pacing, Defibrillation and Resynchronization Therapy

View full text Add to dashboard Cite

Section: Prelude To First Use Of Stand-alone Subcutaneous Defibrillatormentioning

confidence: 99%

Section: Overview Of Experience To Datementioning

confidence: 99%

Subcutaneous Implantable Cardioverter-Defibrillators

Smith¹,

Bardy²,

Hood³

et al. 2011

Clinical Cardiac Pacing, Defibrillation and Resynchronization Therapy

View full text Add to dashboard Cite

“…7 The use of an epicardial or nontransvenous system in a growing, active child is of concern because the fragility of the lead and patch system may, when broken, result in inappropriate shocks because of oversensing (leads) or suboptimal delivery of energy (broken patch). 1,[8][9][10][11] Gradaus et al recently reported successful use of a subcutaneous array lead in 2 children with complex congenital heart diseases that were cured with abdominally placed nontransvenous ICDs. 3 We have shown that the new subcutaneous coil electrode can be used to replace a fractured subcutaneous patch electrode, needed for clean arrhythmia termination with excellent defibrillation thresholds and successful defibrillation results.…”

Section: Fracture Of the Subcutaneous Patch Electrode In A Patientmentioning

confidence: 99%

Fracture of the Subcutaneous Patch Electrode in a Patient With an Implanted Cardioverter-Defibrillator

Milašinović¹,

Jelić²,

Savić³

et al. 2005

Circ J

View full text Add to dashboard Cite

“…Implantable cardioverter defibrillator (ICD) therapy is increasingly indicated in the pediatric population for primary electrical diseases and arrhythmias associated with cardiomyopathies or congenital heart disease (CHD) 1,2 . When first designed, these systems were implanted utilizing high‐voltage epicardial patches; 3,4 currently, most high voltage leads are placed transvenously 5 .…”

Section: Introductionmentioning

confidence: 99%

A Multicenter Experience with Novel Implantable Cardioverter Defibrillator Configurations in the Pediatric and Congenital Heart Disease Population

Stephenson

Batra

Knilans

et al. 2006

Cardiovasc electrophysiol

View full text Add to dashboard Cite

Introduction: In pediatric and congenital heart disease patients, transvenous ICD implantation may be limited secondary to patient size, venous, or cardiac anatomy. Epicardial patches require a thoracotomy, and may lead to a restrictive pericardial process. Because of these issues, we have explored novel ICD configurations. Methods: Retrospective review at 10 centers implanting ICDs without a transvenous shocking coil or epicardial patches. Results: Twenty‐two patients underwent implant at a mean age of 8.9 years (range: 0.3–43.5), with a mean weight of 25.5 kg (range: 5.2–70). Diagnoses included complex CHD, intracardiac tumors, cardiomyopathy, idiopathic VT, LV noncompaction, and long QT syndrome. Three configurations were used: subcutaneous array, a transvenous design ICD lead placed on the epicardium, or a transvenous design ICD lead placed subcutaneously. Difficulties were found at implant in 8 patients: 4 had difficulty inducing VT/VF, and 4 had high DFTs. Over a mean follow‐up of 2.2 years (range: 0.2–10.5), 7 patients had appropriate shocks. Inappropriate shocks occurred in 4 patients. System revisions were required in 7 patients: 2 generator changes (in 1 patient), 3 pace‐sense lead replacement, 1 additional subcutaneous coil placement due to increased DFT, 1 upgrade to a transvenous system, and 1 revision to epicardial patch system. Conclusions: ICD implantation can be performed without epicardial patches or transvenous high‐energy leads in this population, using individualized techniques. This will allow ICD use in patients who have intracardiac shunting or are deemed too small for transvenous ICD leads. The long‐term outcome and possible complications are as yet unknown in this population, and they should be monitored closely with follow‐up DFTs.

show abstract

Implantable Defibrillators in Children: From Whence to Shock

Cited by 12 publications

References 1 publication

Subcutaneous Implantable Cardioverter-Defibrillators

Subcutaneous Implantable Cardioverter-Defibrillators

Fracture of the Subcutaneous Patch Electrode in a Patient With an Implanted Cardioverter-Defibrillator

A Multicenter Experience with Novel Implantable Cardioverter Defibrillator Configurations in the Pediatric and Congenital Heart Disease Population

Contact Info

Product

Resources

About